Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating and breast lobular hyperplasia and cyst

A breast lobular hyperplasia and drug technology, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of long treatment course, easy recurrence, low cure rate, etc., and achieve quick results

Inactive Publication Date: 2010-12-01
孙士光
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Existing drugs for the treatment of this disease include: Rupixiao, Xiaoyao Pills, Asparagine, etc., but there are more or less shortcomings such as slow effect, long course of treatment, low cure rate, easy recurrence, etc.
At present, there is no specific drug for the treatment of breast lobular hyperplasia and cysts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Selection of raw materials: 200 grams of Dandelion, 200 grams of Zihua Diding, 60 grams of Radix Asparagus, 60 grams of Bauhinia Bark, 60 grams of Honeysuckle, 60 grams of Prunella vulgaris, 60 grams of Cyperus Cyperi, 60 grams of Radix Paeoniae Alba, 60 grams of Rhizoma Chuanxiong, Achyranthes bidentata 40 grams, Trichosanthes trichosanthes 35 grams, Angelica sinensis 35 grams; When making, grind each raw material into powder, mix well and prepare powder.

Embodiment 2

[0042] Example 2: Selection of raw materials: 400 grams of Dandelion, 400 grams of Zihua Diding, 90 grams of Radix Asparagus, 90 grams of Bauhinia Bark, 90 grams of Honeysuckle, 90 grams of Prunella vulgaris, 90 grams of Cyperus Cyperi, 90 grams of Radix Paeoniae Alba, 90 grams of Rhizoma Chuanxiong, 70 grams of Achyranthes bidentata, 55 grams of Trichosanthes trichosanthes, and 55 grams of angelica; when making, grind each raw material into powder, and mix them evenly to make a powder.

Embodiment 3

[0043] Example 3: Select raw materials: 200 grams of Dandelion, 200 grams of Zihua Diding, 60 grams of Radix Asparagus, 60 grams of Bauhinia Bark, 60 grams of Honeysuckle, 60 grams of Prunella vulgaris, 60 grams of Rhizoma Cyperi, 60 grams of Radix Paeoniae Alba, 60 grams of Rhizoma Chuanxiong, 40 grams of Achyranthes knuckles, 35 grams of Trichosanthes, 35 grams of angelica, 60 grams of astragalus, 60 grams of oysters, 60 grams of salvia miltiorrhiza, 60 grams of frankincense, 60 grams of Wangbuliuxing, 60 grams of Panax notoginseng; Powder, mixed evenly to prepare powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating and breast lobular hyperplasia and cyst and relates to the medicament for treating hyperplasia of mammary glands. The medicament comprises the following raw materials in part by weight: 100 to 500 parts of mongolian dandelion herb, 100 to 500 parts of philippine violet herb, 50 to 100 parts of radix asparagi, 50 to 100 parts of kadsura toot-bark, 50 to 100 parts of honeysuckle, 50 to 100 parts of common selfheal fruit-spike, 50 to 100 parts of nutgrass galingale rhizome, 50 to 100 parts of white paeony root, 50 to 100 parts of szechuan lovage rhizome, 30 to 80 parts of chaff flower root, 30 to 60 parts of snakegourd fruit and 30 to 60 parts of Chinese angelica. In addition, raidx astragali, oyster shell, danshen root, frankincense, cowherb seed, sanchi, safflower, radix curcumae, figwort, green tangerine peel, trogopterus dung and chicken's gizzard-membrane also can be added into the medicament. The medicament has the effects of soothing liver, relieving upset, softening hard lumps, dispelling nodes, regulating vital energy, alleviating pain, promoting blood circulation, removing blood stasis and the like, is clear in treatment effect on reducing swelling and easing pain, and on improving symptom, and has the advantages of no toxicity and untoward reaction, quick effect and no relapse. Statistics on 367 patients treated by the medicament show that the recovery rate is 90.5 percent and the total effective rate is 100 percent.

Description

Technical field: [0001] The invention relates to a medicine for treating mammary gland hyperplasia, especially a medicine for treating mammary gland lobular hyperplasia and cyst. Background technique: [0002] Breast lobular hyperplasia is the most common non-tumor, non-inflammatory hyperplastic lesion, and is the most common breast disease in women, and its incidence rate ranks first in breast diseases. It may occur at any age after puberty, and it is more common in women aged 20 to 40 with irregular menstruation, less menstruation, short menstruation, unmarried, childless, non-breastfeeding or poor lactation. The main manifestations are breast pain, most of which have a flat mass in the upper quadrant of the breast, with firm and hard nodules the size of bean grains, which may be tender to the touch. There may be distending pain in the breast, which grows and fades with emotions, often aggravates before menstruation, and relieves after menstruation. [0003] Modern medic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8965A61K36/9066A61P15/14A61K35/24A61K35/37A61K35/56A61K35/57A61K35/618
Inventor 孙士光
Owner 孙士光
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products